ANGIOGENIC ASSESSMENT OF ORBCEL (TM), A NOVEL STROMAL CELL POPULATION FOR TREATING CRITICAL LIMB ISCHAEMIA (CLI)

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume19
Publication statusPublished - 1 May 2017

Cite this